Cargando…
Rational Design of a Chimeric Derivative of PcrV as a Subunit Vaccine Against Pseudomonas aeruginosa
Pseudomonas aeruginosa (PA) is a major cause of nosocomial infections, which remain an unsolved problem in the clinic despite conventional antibiotic treatment. A PA vaccine could be both an effective and economical strategy to address this issue. Many studies have shown that PcrV, a structural prot...
Autores principales: | Wan, Chuang, Zhang, Jin, Zhao, Liqun, Cheng, Xin, Gao, Chen, Wang, Ying, Xu, Wanting, Zou, Quanming, Gu, Jiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491502/ https://www.ncbi.nlm.nih.gov/pubmed/31068928 http://dx.doi.org/10.3389/fimmu.2019.00781 |
Ejemplares similares
-
Development of a Chimeric Vaccine Against Pseudomonas aeruginosa Based on the Th17-Stimulating Epitopes of PcrV and AmpC
por: Wang, Ying, et al.
Publicado: (2021) -
Self-assembled ferritin nanoparticles displaying PcrV and OprI as an adjuvant-free Pseudomonas aeruginosa vaccine
por: Li, Yuhang, et al.
Publicado: (2023) -
Protective Efficacy of the Trivalent Pseudomonas aeruginosa Vaccine Candidate PcrV-OprI-Hcp1 in Murine Pneumonia and Burn Models
por: Yang, Feng, et al.
Publicado: (2017) -
Protective Efficacy of the OprF/OprI/PcrV Recombinant Chimeric Protein Against Pseudomonas aeruginosa in the Burned BALB/c Mouse Model
por: Fakoor, Mohammad Hadi, et al.
Publicado: (2020) -
Identification of Small Molecules Blocking the Pseudomonas aeruginosa Type III Secretion System Protein PcrV
por: Sundin, Charlotta, et al.
Publicado: (2021)